T Cell Immunosenescence in Inflammatory Skin Diseases: Pathogenesis and Therapeutic Targets
Targeting senescent T cells in inflammatory skin diseases offers a fresh strategy to overcome treatment resistance in psoriasis and eczema.
This systematic review elucidates how T cell immunosenescence contributes to chronic inflammatory skin diseases including psoriasis and atopic dermatitis through senescence-associated secretory phenotype (SASP) and dysregulated signaling pathways. The review synthesizes current biological therapies and small-molecule inhibitors targeting these senescence pathways, proposing targeting senescent T cells or upstream hubs as a strategy for deep disease remission and overcoming therapeutic resistance.
What the study was
- Study design
- Review
- Population
- Patients with psoriasis, atopic dermatitis, rosacea, and seborrheic dermatitis
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Aging Cell
Why it surfaced
Timely review linking immunosenescence biology to inflammatory skin disease pathogenesis and therapeutics; broad relevance to aging and immunotherapy watchlist topics but does not present new primary data.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.